John Armitage's Egerton Capital disclosed a significant reduction in its holdings of MEDLINE INC (MDLN), cutting its position by 19.35% to 13.28 million shares. The stake, valued at $460.92 million as of the reporting period, saw its weight in Egerton's portfolio decrease from 6.28% to 4.69%.
This trade information comes from a quarterly 13F filing, which reports positions held as of September 30, 2026, and does not reflect trading activity in the current quarter. Medline, a major manufacturer and distributor of medical supplies, completed its initial public offering in late 2025. No specific commentary from the investor regarding the motive for this trade has been made public.